605199.SHG Hainan Huluwa Pharmaceutical Group Co Ltd

Healthcare Pharmaceuticals Shanghai Stock Exchange
5.30 CNY
Close of Nov 5, 2026
5.15 10.32
Market cap
CNY 2.12B
P/E
-
P/B
6.96x
ROE
-75.8%
Dividend yield
1.58%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 605199.SHG undervalued?

Graham number

The Graham number of Hainan Huluwa Pharmaceutical Group Co Ltd cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Hainan Huluwa Pharmaceutical Group Co Ltd fundamental analysis

No fundamental analysis for Hainan Huluwa Pharmaceutical Group Co Ltd yet.

Hainan Huluwa Pharmaceutical Group Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Hainan Huluwa Pharmaceutical Group Co Ltd

Hainan Huluwa Pharmaceutical Group Co., Ltd. research, develops, produces, and sells drugs in the areas of digestive system, respiratory system, anti- infective, anti-virus and other fields in China. It offers pediatrics, gynecology, antibiotics, respiratory, digestive system, cardiovascular and cerebrovascular, nourishment, and other medicine products. The company was founded in 2005 and is based in Haikou, China.

Full company profile